Analysts and Broker commentary, page-2

Not sure how Ord can justify a $10 target price, that's somewhat fanciful thinking. It is looking good at current levels though, trading below the IPO price as of today but now with almost double the store footprint of 12 months ago. SLA is pretty illiquid so it doesn't take much volume to push the prices down (or up). I wonder how much further it can drop...

My high level calcs put this at ~10x trailing EBITDA, ~12x trailing P/E for a fast growing, well run business with significant management alignment. Seems to be one of the few good value stocks at the moment. I'm keen to hear results next week and get an update on the impact of the latest lockdowns - only 37 of 117 clinics are in NSW and VIC, so I'd expect the majority of the clinics should still be operating without too much disruption.